Oregon Therapeutics
Oregon Therapeutics is a developer of new anti-cancer drugs.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Oregon Therapeutics Information
Geographic Data
Address:
City: Paris
State: Ile-de-France
Zip:
Country: France
Financial Info
Stage:
series unknown
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Oregon Therapeutics is developing XCE853 : disruptive targeted therapy “first in class” and “best in class” in oncology. XCE853 is based on an innovative and unique mechanism of action: inhibition of protein disulfide isomerase. OregonTherapeutics first objective is to bring XCE853 into the clinical phase for the treatment of cancer within 2 years. Based on the scientific rationale to exploit the metabolic vulnerability of some cancers, the two priority indications are ovarian cancer and advanced pancreatic cancer.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
